MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.tracli.2024.11.002

Медицинская библиотека · Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2024

Comparative evaluation of hematological parameters and instrument performance in single and double plateletpheresis procedures using Haemonetics MCS+ and Trima Accel systems.

Babaahmadi Niloufar Kazemi, Kheirandish Maryam, Teimourpour Amir, Mohammadi Saeed, Nazemi Amir Masoud

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Plateletpheresis (PP) has become increasingly prevalent due to its cost-effectiveness and fewer immunological and infectious complications for recipients. This study compares hematological indices of platelet donors and instrument-related parameters in high-yield PP donors using Haemonetics MCS+ and Trima Accel.

METHODS

Eligible and healthy PP donors meeting the platelet donation criteria were randomly selected.19 single-dose platelet (SDP), and 26 double-dose platelet (DDP) donors underwent PP using the Haemonetics MCS+, while 21 SDP and 21 DDP donors were processed using the Trima Accel system. Complete Blood Count (CBC) and hematological indices of donors between groups with both devices were measured with the cell counter. Platelet yield, collection efficiency (CE), and collection rate (CR) were evaluated for both devices. Results were reported using R-4.3.2 software and a p-value <0.05 was considered statistically significant.

RESULTS

The Trima Accel processed significantly more blood volume and had shorter procedure times than MCS+. Platelet yield in the SDP group with Trima Accel was significantly higher than the Haemonetics MCS+. The Trima Accel demonstrated a significantly higher CR and CE than the MCS+ in both SDP and DDP groups. Post-PP lymphocyte counts significantly decreased with the Trima compared to the MCS+ in the SDP group. However, post-PP hematocrit (HCT), mean corpuscular volume (MCV), and mean platelet volume (MPV) in the DDP group with the MCS+ were significantly lower than Trima.

CONCLUSION

Double-dose plateletpheresis (DDP) offers advantages in cost-effectiveness and platelet production, and although it reduces some hematological indices, these remain within normal limits. The Trima Accel may offer superior efficiency and processing times compared to the MCS+. However, careful monitoring of DDP donors following AABB standards remains essential.

Для цитирования: Babaahmadi Niloufar Kazemi, Kheirandish Maryam, Teimourpour Amir, Mohammadi Saeed, Nazemi Amir Masoud. Comparative evaluation of hematological parameters and instrument performance in single and double plateletpheresis procedures using Haemonetics MCS+ and Trima Accel systems.. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2024. DOI: 10.1016/j.tracli.2024.11.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.